Perceptive Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-88,500
Closed -$5.22M 98
2025
Q2
$5.22M Buy
+88,500
New +$5.72M 0.19% 66
2018
Q1
Sell
-113,100
Closed -$4.65M 148
2017
Q4
$4.65M Buy
+113,100
New +$3.96M 0.15% 74
2016
Q3
Sell
-50,000
Closed -$1.19M 203
2016
Q2
$1.19M Buy
+50,000
New +$1.2M 0.08% 95
2014
Q2
Sell
-170,000
Closed -$4.52M 131
2014
Q1
$4.52M Buy
+170,000
New +$4.04M 0.47% 48

Other funds holding GMED

Perceptive Advisors's GMED Position: Q3 2025 in Review

Perceptive Advisors sold out of Globus Medical (GMED) in Q3 2025, closing a stake of 88,500 shares — an estimated $5.22M sold.

Perceptive Advisors first reported a position in GMED in Q1 2014 and held it in 4 quarters. The position peaked at $5.22M in Q2 2025. 489 funds tracked by Wall St. Rank hold GMED as of Q3 2025.

  • Perceptive Advisors reported no remaining Globus Medical position as of Q3 2025 after selling out during the quarter.
  • Perceptive Advisors sold 88,500 Globus Medical shares in Q3 2025, an estimated $5.22M.
  • Perceptive Advisors first reported a position in Globus Medical in Q1 2014 and held it in 4 quarters.
  • Perceptive Advisors's Globus Medical position peaked at $5.22M in Q2 2025.
  • 489 funds tracked by Wall St. Rank held Globus Medical as of Q3 2025.

Based on Perceptive Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.